ITCH ‐Mediated Ubiquitination and Degradation of THBS1 : A Key Mechanism for Enhancing Mitochondrial Biogenesis and Alleviating Mouse Skeletal Muscle Atrophy
Acta Physiologica · 2026
DOI: 10.1111/apha.70299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Physiologica, 2026. Verfasst von Wan Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Thrombospondin 1, Muscular Atrophy, Ubiquitin-Protein Ligases, Ubiquitination. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, "Announce the List and Take Charge" Major Scientific and Technological Projects of Liaoning Province.
Abstract (Originalsprache)
Aim
Skeletal muscle atrophy is tightly associated with maladaptive alterations in mitochondrial function and morphology. Itchy E3 ubiquitin‐protein ligase (ITCH) modulates mitochondria, and thrombospondin 1 (THBS1) positively regulates muscle atrophy, but their roles in muscle atrophy are unclear.
Methods
A muscle atrophy model was established in C57BL/6 mice via daily intraperitoneal injection of dexamethasone (Dex, 20 mg/kg). ITCH overexpression in skeletal muscle was achieved by adeno‐associated virus serotype 9 injection. C2C12 cells were treated with 50 μM Dex to mimic in vitro muscle atrophy. Skeletal muscle atrophy in mice was evaluated using hematoxylin–eosin staining and immunofluorescence staining. Mitochondrial damage was assessed via transmission electron microscopy, succinate dehydrogenase staining, and JC‐1 staining. Immunoprecipitation‐liquid chromatography/mass spectrometry, molecular docking, and co‐immunoprecipitation were used to investigate the interaction between ITCH and THBS1. Phosphoproteomics analysis was performed to detect the THBS1 downstream proteins.
Results
Dex treatment downregulated ITCH expression in skeletal muscle. ITCH overexpression increased body weight, muscle mass, and muscle strength, downregulated the expression of atrophy‐related genes (Atrogin‐1, Mstn, MuRF‐1), and promoted mitochondrial biogenesis. The results of the C2C12 cells were consistent with those obtained in vivo. Proteomic profiling and Co‐IP confirmed ITCH–THBS1 interaction and subsequent THBS1 ubiquitination. THBS1 knockdown reduced the expression of Atrogin‐1 and MuRF‐1 and inhibited the phosphorylation of JUN and Map3k7, whereas THBS1 overexpression reversed the ITCH‐mediated improvement in mitochondrial biogenesis.
Conclusion
ITCH enhances mitochondrial biogenesis and mitigates Dex‐induced muscle atrophy by promoting the ubiquitin‐dependent degradation of THBS1 and subsequent inhibition of downstream JUN/Map3k7 phosphorylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, Shenyang, China.
ORCID-Profile: Wan Yu, Difei Wang
Förderung
- National Natural Science Foundation of China
- "Announce the List and Take Charge" Major Scientific and Technological Projects of Liaoning Province
Zitieren
APA
Yu, W., Wang, Y., Li, N., & Wang, D. (2026). ITCH ‐Mediated Ubiquitination and Degradation of THBS1 : A Key Mechanism for Enhancing Mitochondrial Biogenesis and Alleviating Mouse Skeletal Muscle Atrophy. Acta Physiologica. https://doi.org/10.1111/apha.70299
Vancouver
Yu W, Wang Y, Li N, Wang D. ITCH ‐Mediated Ubiquitination and Degradation of THBS1 : A Key Mechanism for Enhancing Mitochondrial Biogenesis and Alleviating Mouse Skeletal Muscle Atrophy. Acta Physiologica. 2026. doi:10.1111/apha.70299
BibTeX
@article{Yu2026,
author = {Yu, Wan and Wang, Yanteng and Li, Na and Wang, Difei},
title = {ITCH ‐Mediated Ubiquitination and Degradation of THBS1 : A Key Mechanism for Enhancing Mitochondrial Biogenesis and Alleviating Mouse Skeletal Muscle Atrophy},
journal = {Acta Physiologica},
year = {2026},
doi = {10.1111/apha.70299}
}
EUVIMED